We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Northstar Neuroscience, a privately held developer of medical devices for the
treatment of neurological diseases and disorders, announced that the FDA has
granted approval for a pivotal clinical study of its investigational cortical
stimulation system to enhance the recovery of hand/arm function following stroke.
Vanguard Medical Concepts has been allowed to resume reconditioning of a medical
device called an endoscopic trocar, now that the FDA has cleared the company
to resume sale of the product.
Roche Diagnostics announced it has reached an agreement with Applera to expand
its PCR licensing program to incorporate enabling patents for real-time PCR
and other important PCR-related technology.
Medical Ventures (MEV) announced the signing of its first distribution agreements
and sales of Performance Medical Devices' PeriPatch Sheet in the U.S. Agreements
have recently been completed with: Corthomed, covering New York, Connecticut
and New Jersey; Kand Medical, covering Southern California and Nevada; and Coast
BioSystems Medical, covering Northern California.
Varian announced a new magnetic resonance imaging system (MRI), which operates
at magnetic field strengths ranging from 4.7 Tesla to 14.1 Tesla and is capable
of a variety of biomedical and material sciences applications.
A recent study has shown physician use of a prescribed set of highly sophisticated
ICD heart rhythm detection and therapy parameters can help reduce the proportion
of fast heart rhythm episodes shocked with high-energy electrical therapy in
people with an implantable cardioverter-defibrillator (ICD).